All microarray data presented in this study is scheduled for upload and presentation by individual gene and time course at the genome web site, ToxoDB, which is part of EuPathDB (http://eupathdb.org/eupathdb/).
For ChIP-chip analyses, details should be provided for how H3K9me2 profiles were obtained and the methods utilized should conform with normally accepted practices for microarray data processing and presentation.
One common data structure of a microarray data set is the presentation of a matrix.
There is an associated interactive software for presentation of microarray data, displaying data as tables, charts, or "matrices," selective data retrieval, filtering, sorting, and deep mining of every data point.
The array data is deposited at Gene Expression Omnibus (GEO), (http://www.ncbi.nlm.nih.gov/geo) and the MIAME (minimal information about a microarray experiment) guidelines was followed for data presentation.
LAHZ helped in the design, analysis, interpretation and presentation of the microarray data.
Detailed presentation of mouse microarray data for metronomic CPA-treated U251 and 9L tumors.
Detailed presentation of human microarray data for U251 tumors on metronomic CPA treatment days 12 and 18.
All presented microarray data is MIAME compliant.
For convenience of presentation, we converted the microarray data for arsenite and vehicle treatment groups to the percentage of their respective abundance at time 0, which was set as 100%.
